Justices Warned That Biogen's Loss Will End Drug Patents
By Andrew Karpan ( July 18, 2022, 9:10 PM EDT) -- The top lobbying groups for the pharmaceutical and biotech industry have told the U.S. Supreme Court that a loss one of their members suffered at the Federal Circuit in a fight with a generic drugmaker over a patent covering the blockbuster multiple sclerosis drug Tecfidera will "effectively prevent patenting" drugs over the long haul....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.